Clinical Trial

Serum Uric Acid in Adolescents With Primary Headache: A Case-Control Study

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 10, 2026 (before its estimated May 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This observational, case-control study will evaluate differences in serum uric acid and related hematologic and biochemical parameters between adolescents (12-18 years) with primary headache and age-/sex-matched controls without recurrent headaches or chronic medical/psychiatric disorders. Cases will meet International Classification of Headache Disorders, 3rd edition (ICHD-3) criteria verified by a pediatric neurologist after comprehensive clinical assessment. The study will also collect sociodemographic data and anthropometrics to calculate BMI. Primary outcome is the between-group difference in serum uric acid levels at enrollment. Secondary outcomes include group differences in ferritin, creatinine, BUN, complete blood count indices (Hb, WBC, neutrophils, lymphocytes, platelets, MPV), and BMI.
Trial Details
NCT Number NCT07460830
Lead Sponsor Konya Necmettin Erbakan Üniversitesi
Conditions Primary Headache Disorders
Enrollment 80 participants
Start Date 2026-03-15
Primary Completion 2026-05-15 (estimated)
Study Completion 2026-05-15 (estimated)
Updated on ClinicalTrials.gov 2026-03-10